Kannalife Sciences, Inc. Email Format
Pharmaceutical ManufacturingPennsylvania, United States2-10 Employees
Kannalife Sciences, Inc. is a biopharmaceutical company focused on developing synthetic cannabinoid–inspired therapeutics for neurodegenerative and neuropathic diseases. It operates as a subsidiary of Neuropathix, Inc. and is based in Doylestown, Pennsylvania, at the Pennsylvania Biotechnology Center. Its lead candidate, KLS-13019, is designed to address drivers of neuroinflammation and mitochondrial dysfunction. It pursues globally patented therapeutic approaches within the pharmaceutical manufacturing sector and targets pathways such as mNCX-1, GPR55, and the NLRP3 inflammasome. With a lean organizational footprint, the company advances its development program toward clinical evaluation.